SCHEMBL17835142

SCHEMBL17835142

CCCCNC(=O)c1ccc(C(=O)c2ccccc2)cc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.76
SMN1; SMN2 Q16637 1/20 0.68
TSHR P16473 1/20 0.62
HTT P42858 1/20 0.62
DRD2 P14416 2/20 0.60
DRD4 P21917 2/20 0.60
DRD3 P35462 2/20 0.60
LMNA P02545 2/20 0.60
POLB P06746 1/20 0.60
HDAC3 O15379 4/20 0.59
HDAC1 Q13547 4/20 0.59
HDAC2 Q92769 4/20 0.59
L3MBTL1 Q9Y468 1/20 0.59
NPC1 O15118 2/20 0.58
RAB9A P51151 2/20 0.58
HDAC8 Q9BY41 2/20 0.57
TDP1 Q9NUW8 1/20 0.57
HDAC4 P56524 1/20 0.57
HDAC7 Q8WUI4 1/20 0.57
HDAC10 Q969S8 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11355945 0.94 NAAA (0.88) NAAASMN1; SMN2DRD2DRD4DRD3
SCHEMBL1002854 0.93 NAAA (0.86) NAAASMN1; SMN2TSHRHTTDRD2
Hydrochloric Acid SCHEMBL15954598 0.91 NAAA (0.83) NAAASMN1; SMN2TSHRHTTDRD2
Bromide SCHEMBL4760760 0.91 NAAA (0.83) NAAASMN1; SMN2TSHRHTTDRD2
SCHEMBL9503009 0.91 NAAA (0.83) NAAASMN1; SMN2TSHRHTTDRD2
SCHEMBL17226037 0.90 NAAA (0.65) NAAASMN1; SMN2DRD2DRD4DRD3
SCHEMBL1003680 0.88 NAAA (0.96) NAAASMN1; SMN2TSHRHTTDRD2
SCHEMBL28326194 0.88 L3MBTL1 (0.73) NAAASMN1; SMN2TSHRHTTDRD2
SCHEMBL6360275 0.87 DRD2 (0.78) NAAASMN1; SMN2TSHRHTTDRD2
SCHEMBL1002305 0.86 NAAA (1.00) NAAASMN1; SMN2HTTDRD2DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10017520-B2 Myc modulators and uses thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2018-07-10 US disclosed
US-20160168165-A1 MYC MODULATORS AND USES THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160168165-A1 MYC MODULATORS AND USES THEREOF MYC, MYCBP, MYCBP2 NAAA 4719/4885SMN1; SMN2 4149/4885TSHR 3768/4885
US-10017520-B2 Myc modulators and uses thereof MYC, MYCBP, MYCBP2 NAAA 4719/4885SMN1; SMN2 4149/4885TSHR 3768/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.